Skip to main content
logo
OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
3.790
-0.040 (-1.04%)
Aug 28, 2026, 4:00 PM EDT - Market closed

OnKure Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
15339115--
Market Cap Growth
305.14%-65.75%---
Enterprise Value
-22-30243--
Last Close Price
3.792.908.60--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.890.701.11--
P/TBV Ratio
0.890.701.11--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.010.020.06
Net Debt / Equity Ratio
-1.02-1.04-1.06-1.04-1.09
Net Debt / EBITDA Ratio
2.840.942.070.800.37
Net Debt / FCF Ratio
3.671.132.140.840.39
Quick Ratio
26.559.9710.524.102.08
Current Ratio
26.7510.2810.734.642.46
Return on Equity (ROE)
-46.91%-74.39%-79.92%-186.07%-
Return on Assets (ROA)
-29.27%-44.45%-44.43%-89.24%-
Return on Capital Employed (ROCE)
-36.00%-112.00%-51.30%-129.80%-284.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-38.25%-151.48%-45.91%--
FCF Yield
-31.19%-132.03%-44.60%--
Buyback Yield / Dilution
-126.66%-292.10%-1114.54%--
SEC Filings: 10-K · 10-Q